
Auteur J. D. LEE
|
Documents disponibles écrits par cet auteur (4)

J. BERK ; B. DEL POZO ; J. D. RICH ; J. D. LEE | 2022
Dans Journal of Addiction Medicine (Vol.16, n°4, July-August 2022) Article : PériodiqueAs the opioid overdose cases rise, policy-makers and researchers should target interventions to populations at highest risk. Incarceration serves as a risk factor for opioid overdose (Gan et al. Addiction 2021) and a large portion of recent over[...]
B. TOFIGHI ; J. D. LEE | 2012
Dans Journal of Addiction Medicine (Vol.6, n°3, September 2012) Article : PériodiqueBACKGROUND: Since 2004, a new wave of synthetic cannabinoids (SCs) known as "Spice drugs" has come under scrutiny because of their suspected link to neurological and psychiatric sequelae. These "herbal incense" or "potpourri blends" have gained [...]
A. CHENG ; R. BADOLATO ; A. SEGOSHI ; R. McDONALD ; M. MALONE ; K. VASUDEVAN ; B. BADIEI ; A. SUGARMAN ; R. MACDONALD ; J. MANGAT ; J. GIFTOS ; J. D. LEE ; B. TOFIGHI | 2022
Dans Addiction Science and Clinical Practice (Vol.17, 2022) Article : PériodiqueBackground: Extended-release buprenorphine (XRB) offers a novel approach to sustained monthly treatment for people who use opioids in criminal justice settings (CJS). This study explores the experiences of adults receiving XRB as a jail-to-commu[...]
B. TOFIGHI ; N. LEONARD ; P. GRECO ; A. HADAVAND ; M. C. ACOSTA ; J. D. LEE | 2019
Dans Journal of Addiction Medicine (Vol.13, n°4, July-August 2019) Article : PériodiqueBACKGROUND: Technology-based interventions offer a practical, low-cost, and scalable approach to optimize the treatment of substance use disorders (SUDs) and related comorbidities (HIV, hepatitis C infection). This study assessed technology use [...]